欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NO/H/0163/003
药品名称Kandrozid
活性成分
    • candesartan 16.0 mg
剂型Tablet
上市许可持有人Generics [UK] Ltd (a Mylan company) Albany Gate, Darkes Lane Potters Bar, EN6 1AG United Kingdom
参考成员国 - 产品名称Norway (NO)
Kandrozid
互认成员国 - 产品名称
    • Germany (DE)
      Candersartan dura 16 mg Tabletten
    • Denmark (DK)
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Spain (ES)
    • Portugal (PT)
    • Sweden (SE)
    • Finland (FI)
许可日期2011/02/17
最近更新日期2024/06/04
药物ATC编码
    • C09CA06 candesartan
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase